Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Regencell Bioscience Holdings Limited (RGC) had Cash Flow from Investing Activities of $2.69M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$4.90M |
|
$1.07M |
|
$1.17M |
|
$5.76M |
|
$0.66M |
|
-- |
|
-- |
|
$0.90M |
|
$4.86M |
|
$4.86M |
|
$4.86M |
|
-- |
|
| Cash Flow Statement Financials | |
$-3.11M |
|
|
Cash Flow from Investing Activities |
$2.69M |
$0.00M |
|
$2.96M |
|
$2.42M |
|
$-0.54M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|